Vera Therapeutics VERA Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's prepaid & other current?
- Vera Therapeutics (VERA) reported prepaid & other current of $19.04M in Q1 2026.
- How has Vera Therapeutics's prepaid & other current changed year-over-year?
- Vera Therapeutics's prepaid & other current increased by 17.2% year-over-year, from $16.24M to $19.04M.
- What is the long-term trend for Vera Therapeutics's prepaid & other current?
- Over 4 years (2021 to 2025), Vera Therapeutics's prepaid & other current has grown at a 47.1% compound annual growth rate (CAGR), from $12.61M to $58.99M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.